Wegovy vs. Ozempic: what is the difference?

If you're managing overweight and obesity or living with type 2 diabetes, you may have wondered about Wegovy vs. Ozempic. Both are GLP-1 (glucagon-like peptide-1 receptor agonists) medications and contain the same active ingredient, semaglutide. The main differences are the amount of semaglutide in each pen, what they're approved for, and their available forms.

Keep reading to understand the key differences between Wegovy vs. Ozempic. 

Wegovy and Ozempic are brand-name prescription medications containing the same active ingredient: semaglutide. Both belong to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists or GLP-1s). Other medications in this class include Rybelsus (an oral medication), Saxenda, Trulicity, and Victoza.

How does Ozempic work?

Ozempic works by mimicking the natural hormone GLP-1: it binds to GLP-1 receptors and signals the pancreas to release insulin into the bloodstream when blood sugar rises. Increased insulin brings blood sugar levels back down.

Since Ozempic mimics the GLP-1 hormone, it helps stabilize blood glucose in people with type 2 diabetes.

Ozempic also delays gastric emptying, which can slow how quickly nutrients from a meal enter the bloodstream. It can also reduce appetite and food intake.

Finally, GLP-1 receptor agonists such as Ozempic tell the brain you’re full after eating. This adds another layer of appetite regulation. 

Because of these effects on appetite and food intake, Ozempic is often prescribed off-label for weight loss. 

How does Wegovy work?

Semaglutide is the active ingredient in both Ozempic and Wegovy, so Wegovy works the same way as Ozempic does. 

By activating GLP-1 receptors, Wegovy keeps food in the stomach for longer and also sends signals to the brain, letting it know you’re full. All of that helps regulate your appetite and leads to significant weight loss.

In one clinical trial, participants who took the 2.4 mg of injectable Wegovy lost an average 15% of body weight after 68 weeks. 

In another clinical trial, participants who took 25 mg of Wegovy pill daily lost an average of 14% of body weight after 64 weeks.  

Although Ozempic and Wegovy share many similarities, the FDA has approved Ozempic and Wegovy for different uses.  

Ozempic is FDA-approved for:

• Controlling blood sugar in adults with type 2 diabetes mellitus

• Reducing the risk of major cardiovascular health problems, such as heart attack, stroke, and death in adults with type 2 diabetes and cardiovascular disease

• Reducing the risk of kidney decline in adults with type 2 diabetes and chronic kidney disease

The Ozempic pill (which is replacing Rybelsus) is FDA-approved for:

• Controlling blood sugar in adults with type 2 diabetes mellitus

• Reducing the risk of major cardiovascular health problems, such as heart attack or stroke, in adults with type 2 diabetes and who have a high risk of heart issues

Note: The Ozempic pill replaces Rybelsus, an older oral semaglutide formulation. As of May 2026, Rybelsus is being phased out in favor of the Ozempic pill, though inventory of the original Rybelsus doses (3 mg, 7 mg, and 14 mg) will remain available until depleted.

Wegovy (injection) is FDA-approved, alongside a reduced-calorie diet and exercise, for:

• Weight loss and management in adults and pediatric patients aged 12 years and older with obesity

• Weight loss and management in adults with overweight and at least one weight-related health condition (e.g. diabetes)

• Cardiovascular risk reduction in adults with cardiovascular disease and either obesity or overweight 

• Treatment of MASH, a more serious form of fatty liver disease 

The Wegovy pill is FDA-approved, alongside a reduced-calorie diet and exercise, for:

• Weight loss and management in adults with obesity or overweight and at least one weight-related health condition (e.g. diabetes)

• Cardiovascular risk reduction in adults with cardiovascular disease and either obesity or overweight 

Another notable difference between the two medications is how you use the pens. Wegovy comes in different injection devices. Some Wegovy pens are single-dose and discarded after one injection. Wegovy FlexTouch, however, is a single-patient-use pen that contains four weekly 2.4 mg doses and requires you to attach a new needle for each injection. Ozempic pens are available in single-patient-use multidose pens. With these pens, you attach a new needle before each injection, discard the needle afterward, and use the same pen for several doses.

All of the details that differentiate Wegovy vs. Ozempic might be overwhelming. Here are some highlights of several key differences and similarities between these medications:

*Terms and restrictions may apply for certain cash-pay prices on Ro

Whether you’re interested in Wegovy and Ozempic for managing type 2 diabetes, weight loss, or both, speak to your healthcare provider. They can help you determine which medication is right for you and create a safe and effective treatment plan.

See if you qualify

Since Ozempic and Wegovy contain the same active ingredient, semaglutide, side effects are very similar for the drugs. In general, gastrointestinal side effects are most common when you start using Ozempic or Wegovy and as you increase your dose. 

Higher doses of Wegovy and Ozempic may have a higher risk of side effects.

Common side effects of Ozempic and Wegovy include:

• Nausea

• Vomiting

• Abdominal pain

• Diarrhea or constipation

Less common:

• Injection site reactions, such as pain or skin irritation

Serious side effects are possible with Ozempic and Wegovy but are less common. They can include: 

• Pancreatitis (inflammation of the pancreas) or gallbladder problems

• Hypoglycemia (low blood sugar) when taken along with insulin or certain diabetes pills like glimepiride or glipizide 

• Acute kidney injury, particularly if vomiting or diarrhea leads to dehydration

• Diabetic retinopathy complications

• Severe allergic reaction

Because some side effects — particularly gastrointestinal effects — can become more common at higher semaglutide doses, the prescribed dose may affect tolerability.

• In one clinical trial, participants with type 2 diabetes who took 2.4 mg of semaglutide once weekly — the dose used in Wegovy — reported more side effects than those taking 1 mg, the dose typically used for Ozempic.

If you have concerns about potential side effects, speak with your healthcare provider about which drug might be right for you. 

When taking injections, the typical maintenance dose of Wegovy is higher than Ozempic because it comes in higher doses of semaglutide. 

• Ozempic is available in 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths.

• Wegovy is available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg strengths. A 7.2 mg strength (Wegovy HD) is also available for people who've tolerated 2.4 mg and need additional weight loss.

This means Wegovy (injections) can be taken at a higher dose than Ozempic. If appropriate, your healthcare provider can increase your Ozempic dosage to 2 mg once weekly for blood sugar control (the maximum dosage).

A typical Wegovy vs. Ozempic dosage schedule may be as follows, though depending on your response and side effect profile, your breakdown may be different:

In terms of pills, the Wegovy and Ozempic tablets come in similar strengths:

• The Wegovy pill is available in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths. 

• The Ozempic pill is available in 1.5 mg, 4 mg, and 9 mg strengths. 

As of May 2026, Rybelsus is being phased out and transitioning fully to the Ozempic pill. That said, inventory of original Rybelsus doses (3 mg, 7 mg, 14 mg) will remain available until depleted. 

The titration schedule of the Wegovy and Ozempic pills might look like: 

Ozempic's list price is $1,027.51 for a 28-day supply, and the Ozempic pill's list price is the same for a 30-day supply. Wegovy and the Wegovy pill share a list price of $1,349.02 per 28- and 30-day supply, respectively.

If you don't have insurance or prefer to pay cash, you can get Wegovy for the following cash prices on Ro:

• Wegovy (pens): 

  • $199 per month for the first two months*

  • $349–$399 per month thereafter 

• Wegovy pill:

  • $149 per month for 1.5 mg dose

  • $199 per month for 4 mg dose

  • $299 per month for 9 mg and 25 mg doses 

*Terms and restrictions may apply for certain cash-pay prices on Ro.

Novo Nordisk offers a savings card program for the medications, which may bring the cost down significantly if you have private or commercial insurance.

• Ozempic and the Ozempic pill: With the Ozempic Savings Card, you can pay as little as $25 for a one-, two-, or three-month supply if you have insurance coverage for Ozempic and meet additional eligibility requirements. 

• Wegovy pill: With the manufacturer’s savings offer, you may qualify to pay as low as $25 per month (up to a maximum savings of $100 per month) if you have commercial insurance with coverage of the Wegovy pill and meet additional eligibility requirements.

• Wegovy: With the Wegovy Savings Card, you can pay as little as $25 per month if you have insurance coverage for Wegovy. If you're uninsured or pay cash for your prescriptions, the manufacturer offer caps the monthly cost of the medication at $349–$399 per refill.

If you have insurance through a state or federal program, such as Medicare, Medicaid, or the VA, you are not eligible for either offer. However, you may still be able to save on Wegovy or Ozempic by using free pharmacy discount cards, such as those offered by GoodRx, Optum Perks, and others. 

Clinical trials have shown substantial weight loss with several semaglutide formulations and doses. While these results from separate studies should not be treated as direct comparisons, some trials have led to more weight loss than others.

Here’s what the research shows:

• In a clinical trial, people without diabetes who took 2.4 mg of injectable semaglutide (Wegovy) lost an average of 15% of their body weight after 68 weeks. 

• A 2025 study found that people without diabetes who took 7.2 mg of injectable semaglutide (Wegovy HD) lost an average of 18.7% of their body weight after 72 weeks. 

• In a different study, people with diabetes who took 1 mg of injectable semaglutide (Ozempic) lost an average of 7% of their body weight after 68 weeks. (FYI, research suggests people with diabetes tend to lose less weight on GLP-1s than those without the condition.) 

• In this study, participants with diabetes who took up to 14 mg of oral semaglutide (Rybelsus) lost an average of 4.3 kilograms (9.5 lbs) after 52 weeks. Based on the participants’ average starting weight, this works out to be a loss of about 4.6% of their body weight. 

• And in another clinical trial, people without diabetes who took 25 mg of oral semaglutide (Wegovy pill) lost an average of about 14% of their body weight after 64 weeks. 

It’s worth noting that this research doesn’t directly compare injectable Wegovy to Ozempic to oral Wegovy. Plus, every person is different. So, a healthcare provider can help you determine if one of these medications is right for you. Ro Body, for example, combines access to GLP-1 treatment with personal coaching to help people lose weight and keep it off. 

Whether Wegovy or Ozempic is right for you is a personal decision best made by you with your healthcare provider. There are a number of things to consider when choosing between Wegovy vs. Ozempic, from your current health situation to your insurance coverage and budget.

If you are looking into GLP-1 drugs to manage your type 2 diabetes, the Ozempic pill or injection may be the better option, as they are FDA-approved specifically to treat type 2 diabetes. 

If you’re looking to lose weight, however, Wegovy pill or injection might be a better fit for you given they’re both FDA approved for weight loss. Both forms of Wegovy have also been shown to drive more weight loss than Ozempic, though this information comes from separate studies (not head-to-head research). 

Other factors that might influence your decision of Wegovy vs. Ozempic (or vice versa) include:

• Your tolerance for certain side effects. While the medications share many side effects, the Wegovy label lists additional common adverse reactions, including headache, fatigue, and dizziness, although adverse-event rates from separate Wegovy and Ozempic trials cannot be directly compared. Research also suggests that among the side effects they share — nausea, vomiting, diarrhea, abdominal pain, and constipation — these are more commonly reported at the higher, Wegovy-equivalent dose of semaglutide (2.4 mg) than at Ozempic doses (1 mg).

• Insurance coverage (if any) and budget. Wegovy (tablets and pens) both have a list price of $1,349.02 but are available at lower cash prices through Ro. Ozempic (pills and pens), on the other hand, has a lower list price: $1,027.51.  Insurance coverage for Wegovy varies widely by plan and indication. Medicare coverage rules have also changed: beginning July 1, 2026, eligible Medicare Part D beneficiaries can access Wegovy for weight management through the Medicare GLP-1 Bridge demonstration.

Check your coverage for FDA-approved GLP-1s—for free

Check for free

Ozempic and Wegovy are both brand-name versions of semaglutide. But there are a few key distinguishers when comparing these drugs. Here’s what to keep in mind:

• Ozempic and Wegovy work the same way. They contain semaglutide, which mimics the GLP-1 hormone to help control blood sugar, slow digestion, and reduce appetite.  

• They have different FDA-approved uses. In simple terms, Ozempic is approved for type 2 diabetes (and certain risk-reduction benefits in people with diabetes); Wegovy is approved for weight management (and cardiovascular risk reduction in certain people). 

• They come in different forms. Ozempic is available as a weekly injection and a daily pill, while Wegovy comes as a weekly injection and a daily oral tablet (which is known as the Wegovy pill). 

• Dosage strengths differ. Each semaglutide drug comes in different dosage strengths, ,and doses are increased gradually by your healthcare provider according to its prescribed titration schedule.

• Ozempic and Wegovy share similar side effects. Gastrointestinal side effects are common for the medications, though Wegovy has a longer list of side effects overall. 

At the end of the day, the decision of Wegovy vs. Ozempic should be made alongside your healthcare provider. They’re best equipped to determine which medication may be a fit for you based on your health goals, medical history, and other personal factors.